Clinical Trials Directory

Trials / Completed

CompletedNCT05603689

Effect of Isocaloric Ketogenic Diet on Physical Performance at High Altitude

Effect of a Four-week Isocaloric Ketogenic Diet on Physical Performance at Very High Altitude: a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Clinique Romande de Readaptation · Network
Sex
All
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

A ketogenic diet (KD) reduces daily carbohydrates (CHOs) ingestion by replacing most calories with fat. KD is of increasing interest among athletes because it may increase their maximal oxygen uptake (VO2max), the principal performance limitation at high altitudes. The investigators examined the tolerance of a 4-week isocaloric KD (ICKD) under simulated hypoxia and the possibility of evaluating ICKD performance benefits with a maximal graded exercise bike test under hypoxia and collected data on the effect of the diet on performance markers and arterial blood gases.

Detailed description

In a randomised single-blind cross-over model, 6 recreational mountaineers (age 24 to 44 years) will complete a 4-week ICKD followed or preceded by a 4-week habitual mixed western diet (HD). Performance parameters (VO2max, lactate threshold \[LT\], peak power \[Ppeak\]) and arterial blood gases (PaO2, PaCO2, pH, HCO3-) will be measured at baseline under two conditions (normoxia and hypoxia) as well as after a 4-week HD and 4-week ICKD under the hypoxic condition.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIsocaloric ketogenic dietThe ICKD definition was based on the works of Sansone (2018) and Trimboli (2020). We defined ICKD as a daily CHOs ingestion \< 30 to 50 g.d-1, without any limitation in fat consumption. Participants self-selected their own diet based on a list of advised and forbidden foods developed to fit the definition of ICKD. There were no instructions to limit calories.

Timeline

Start date
2020-09-01
Primary completion
2021-09-01
Completion
2022-09-23
First posted
2022-11-03
Last updated
2022-11-03

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05603689. Inclusion in this directory is not an endorsement.